Yubo Wang
Union Hospital(CN)Xinjiang Medical University(CN)Kunming Medical University(CN)Calmette Hospital(KH)First Affiliated Hospital of Xinjiang Medical University(CN)St. Ann's Episcopal Church(US)Union Hospital(CN)Anyang Hospital of Traditional Chinese Medicine(CN)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, PI3K/AKT/mTOR signaling in cancer, Metabolism, Diabetes, and Cancer, Glioma Diagnosis and Treatment, Gastric Cancer Management and Outcomes
Most-Cited Works
- → Metformin Sensitizes EGFR-TKI–Resistant Human Lung Cancer Cells In Vitro and In Vivo through Inhibition of IL-6 Signaling and EMT Reversal(2014)234 cited
- → Metformin Inhibits the IL-6-Induced Epithelial-Mesenchymal Transition and Lung Adenocarcinoma Growth and Metastasis(2014)107 cited
- → Characterization of an Asymptomatic Cohort of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infected Individuals Outside of Wuhan, China(2020)99 cited
- → Metformin attenuates gefitinib-induced exacerbation of pulmonary fibrosis by inhibition of TGF-β signaling pathway(2015)93 cited
- → Synergistic effects of metformin in combination with EGFR-TKI in the treatment of patients with advanced non-small cell lung cancer and type 2 diabetes(2015)92 cited
- → The mechanosensitive Piezo1 channel: structural features and molecular bases underlying its ion permeation and mechanotransduction